PARTNERSHIP WITH BIOLAB SCIENCES

Advanced biologics.

A curated portfolio of antimicrobial and amniotic biologics — selected for clinical performance, payer alignment, and operational reliability. From entry-level single amnion to tri-layer escalation, one portfolio covers every wound acuity.

Schedule a consultation → Common questions

Portfolio

AntimicrobialMicrolyte SAM
Tri-layerTri-Membrane Wrap
Dual-layerMembrane Wrap
Single amnionMembrane Wrap Lyte
RegulatoryFDA 510(k) K153756
HCPCSA2005 + aligned
Product advantages

One portfolio, every wound acuity.

From sub-cytotoxic antimicrobial coverage to tri-layer ECM escalation — the BioLab Sciences portfolio covers the full spectrum of chronic and acute wound presentations.

Antimicrobial

Microlyte SAM

Sub-cytotoxic silver antimicrobial dressing with broad-spectrum protection — 50–100x lower silver concentration than conventional dressings while achieving equivalent kill rates. FDA 510(k) K153756, HCPCS A2005, bioresorbable within 7 days.

Dual-layer ECM

Membrane Wrap

Dual-layer amnion allograft for moderate chronic wounds — with 2x the extracellular matrix (ECM) payload of single-layer alternatives. Enhanced structural support and concentrated growth factor delivery across a broad range of indications.

Tri-layer

Tri-Membrane Wrap

A-C-A (amnion-chorion-amnion) tri-layer allograft with the highest ECM concentration in the BioLab portfolio. Designed as escalation for failed prior grafts, high-risk patients, and complex wound presentations.

Entry point

Membrane Wrap Lyte

Single-amnion allograft for shallow diabetic foot ulcers and partial-thickness venous leg ulcers. A cost-effective entry point into biologic wound care — essential amniotic growth factors in an accessible format.

Common questions

What to know about the biologics portfolio.

What differentiates Microlyte SAM? +
Microlyte SAM is a sub-cytotoxic silver antimicrobial dressing delivering broad-spectrum antimicrobial protection with 50–100x lower silver concentration than conventional dressings — while achieving equivalent kill rates. FDA 510(k) cleared (K153756), HCPCS A2005. Conforms fully to the wound surface, eliminates dead space, and is bioresorbable within 7 days. Clinical data shows 91% healed or improved outcomes at 12 weeks.
What is Tri-Membrane Wrap? +
Tri-Membrane Wrap is an A-C-A (amnion-chorion-amnion) tri-layer allograft offering the highest ECM concentration in the BioLab Sciences portfolio. Designed as an escalation product for failed prior grafts, high-risk patients, and complex wound presentations — Tri-Membrane Wrap delivers maximum regenerative support where conventional approaches have underperformed.
What is Membrane Wrap? +
Membrane Wrap is a dual-layer amnion allograft designed for moderate chronic wounds. With 2x the extracellular matrix (ECM) payload of single-layer alternatives, Membrane Wrap provides enhanced structural support and concentrated growth factor delivery across a broad range of wound care indications.
What is Membrane Wrap Lyte? +
Membrane Wrap Lyte is a single-amnion allograft indicated for shallow diabetic foot ulcers (DFUs) and partial-thickness venous leg ulcers (VLUs). As a cost-effective entry point into biologic wound care, Membrane Wrap Lyte delivers essential amniotic growth factors and extracellular matrix scaffolding in an accessible format.
Ready when you are

Add advanced biologics to your program.

A 30-minute consultation to walk through product selection, escalation pathways, and reimbursement alignment.

Schedule a consultation → Explore the portfolio